Definitive Healthcare, a leader in healthcare business intelligence, today announced the expansion of medical claims and prescription data coverage to all payers worldwide. . The company’s Atlas Prescription Claims coverage has grown by more than 60%, and the company’s Atlas All-Payer Claims coverage has also grown significantly, including a nearly 20% increase in sales. major areas such as rare diseases, cancer and chronic diseases.With rich claims data, any organization that works with healthcare providers to improve outcomes and patient care can view comprehensive, in-depth information about the journey. of patients throughout the entire healthcare process to better understand market trends, inform product development, and optimize market strategies.
Along with increasing request volume, Definitive Healthcare has refined its methods for mastering patient and payer data for increased accuracy and implemented additional layers of cleaning techniques to allow enabling more detailed reporting and granular data, baseline and longitudinal analysis, and increased accuracy for patient grouping. By improving on the underlying methodology and adding new sources, Definitive Healthcare nearly doubled the size of patient overlap in the dataset.When combined with the broader Atlas dataset, including top referral and affiliate data, the content of the new claim provides Definitive Healthcare customers with advanced insights into provider behavior, the model of linking and referring providers, patient care, and activities that take place in the facility.“The Atlas Dataset is the foundation of our healthcare commercial intelligence, and the expanded coverage of both prescription and all-payor claims will help our clients accelerate their path to commercial success,”
“We’re excited to increase both the quantity and quality of our Atlas claim datasets to paint a more comprehensive picture of a patient’s journey as part of our ongoing strategy to invest in powerful, real-world data. With the Atlas Dataset, our life sciences customers can more easily and quickly get their drugs and devices to the patients that need them.”
Robert Musslewhite, CEO of Definitive Healthcare.
